ENDS Respiratory System: Difference between revisions
| (One intermediate revision by the same user not shown) | |||
| Line 98: | Line 98: | ||
==General== | ==General== | ||
===2024: [https://pubmed.ncbi.nlm.nih.gov/39112772/ The association of vaping and electronic cigarette use with postoperative hypoxemia and respiratory complications: a retrospective cohort analysis]=== | |||
*Conclusion: Vaping/e-cigarette use was neither associated with clinically significant hypoxemia during the first hour in the postanesthesia care unit nor with an increase in pulmonary complications. | |||
**Citation: Saab R, Rivas E, Yalcin EK, Chen L, Montalvo M, Almonacid-Cardenas F, Shah K, Ruetzler K, Turan A. The association of vaping and electronic cigarette use with postoperative hypoxemia and respiratory complications: a retrospective cohort analysis. Can J Anaesth. 2024 Aug 7. English. doi: 10.1007/s12630-024-02801-6. Epub ahead of print. PMID: 39112772. | |||
***Online ahead of print. - No funding/COI information is listed at this time. | |||
===2021: [https://www.sciencedirect.com/science/article/abs/pii/S2213260021000229 Effect of an electronic nicotine delivery system with 0, 8, or 36 mg/mL liquid nicotine versus a cigarette substitute on tobacco-related toxicant exposure: a four-arm, parallel-group, randomised, controlled trial]=== | ===2021: [https://www.sciencedirect.com/science/article/abs/pii/S2213260021000229 Effect of an electronic nicotine delivery system with 0, 8, or 36 mg/mL liquid nicotine versus a cigarette substitute on tobacco-related toxicant exposure: a four-arm, parallel-group, randomised, controlled trial]=== | ||
*Use of an ENDS with cigarette-like nicotine delivery can reduce exposure to a major pulmonary carcinogen, NNAL, even with concurrent smoking. | *Use of an ENDS with cigarette-like nicotine delivery can reduce exposure to a major pulmonary carcinogen, NNAL, even with concurrent smoking. | ||
===2020: [https://www.nber.org/papers/w27507 E-Cigarettes and Respiratory Disease: A Replication, Extension, and Future Directions]=== | ===2020: [https://www.nber.org/papers/w27507 E-Cigarettes and Respiratory Disease: A Replication, Extension, and Future Directions]=== | ||
| Line 293: | Line 298: | ||
===2021: [https://pubmed.ncbi.nlm.nih.gov/27543458/ Lung function and respiratory symptoms in a randomized smoking cessation trial of electronic cigarettes]=== | ===2021: [https://pubmed.ncbi.nlm.nih.gov/27543458/ Lung function and respiratory symptoms in a randomized smoking cessation trial of electronic cigarettes]=== | ||
*[https://sci-hub.se/10.1042/CS20160268 PDF Full version] | *[https://sci-hub.se/10.1042/CS20160268 PDF Full version] | ||
===2024: [https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(24)00530-3/fulltext Functionally important respiratory symptoms and continued cigarette use versus e-cigarette switching: population assessment of tobacco and health study waves 2-6]=== | |||
=More Information= | =More Information= | ||
*Click on the category link below for more studies by topic on ENDS and Nicotine. | *Click on the category link below for more studies by topic on ENDS and Nicotine. | ||
[[Category:Studies, Surveys, and Papers]] | [[Category:Studies, Surveys, and Papers]] | ||